| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $224K | -9.8% |
| SG&A Expense | $57.0M | +4448.4% |
| Operating Income | -$57.3M | -3628.9% |
| Pre-tax Income | -$58.9M | -2922.2% |
| Income Tax | -$129K | +0.0% |
| Net Income | -$58.9M | -3136.6% |
| EPS (Basic) | -$14.85 | — |
| EPS (Diluted) | -$14.85 | — |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Current Assets | $8.4M | — |
| Total Assets | $19.6M | — |
| Current Liabilities | $5.6M | +47.1% |
| Long-term Debt | $538K | +34.7% |
| Total Liabilities | $5.7M | +48.7% |
| Stockholders' Equity | $13.9M | +468.0% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$405K | +56.7% |
| Financing Cash Flow | $491K | -47.9% |